University of Oxford

#Blood cancer #Breast cancer #CAR T-cell therapy #Clinical trial #epilepsy #Gene mutation #Genetic profiling #HER2 #Japan #Lung cancer #Nuclear medicine #Theranostics #University College London #University of Oxford

DDW Highlights: 7 July 2026

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW’s Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news. Last week, experts warned patients were being denied access to personalised cancer care. Cancer… Read More

#Podcasts

#Blood cancer #Breast cancer #CAR T-cell therapy #Clinical trial #epilepsy #Gene mutation #Gene therapy #Genetic profiling #HER2 #Japan #Lung cancer #Nuclear medicine #Theranostics #University College London #University of Oxford #University of Queensland

This week in Drug Discovery (29 June – 3 July) 

News round-up for 29 June – 3 July by Bruno Quinney, Content Team at DDW.  This week, experts warn patients are being denied access to personalised cancer care. Cancer research is a theme elsewhere, with findings emerging from studies into a CAR T-cell therapy, lung cancer and breast cancer.  The… Read More

#News

CAR-T therapy
#Blood cancer #CAR T-cell therapy #University College London #University of Oxford

CAR T-cell therapy selectively targets cancer mutations 

A new CAR T-cell therapy can target key mutations causing rare blood cancers and leave healthy blood cells unharmed, scientists say.  A research effort led by University College London (UCL) and the University of Oxford engineered a CAR T-cell therapy which can reprogramme a patient’s own immune cells… Read More

#Cancer Research #News

Vaccine discovery
#Ebola virus #Immunology / Virology & Vaccines #Outbreak #University of Oxford

UK group steps up Ebolavirus vaccine development in response to outbreak

In response to the current Bundibugyo Ebolavirus outbreak in the Democratic Republic of the Congo, the Oxford Vaccine Group (OVG) has reported that it is working urgently with the Clinical BioManufacturing Facility and the Serum Institute of India (SIIPL) to rapidly produce and scale doses of its ChAdOx-based monovalent… Read More

#News #Trending News

#Genetics #HIV #University of Oxford

HIV treatment may have changed ‘evolutionary trajectory’ 

Antiretroviral therapy (ART) against HIV may have altered the course of human evolution, research says.  A study led by researchers at the University of Oxford, published in Proceedings of the National Academy of Sciences (PNAS), shows that ART is not only transforming outcomes for people living with… Read More

#News

Research in genetics laboratory
#Francis Crick Institute #Genetics #Neurodevelopmental disorders #University of Oxford

Research uncovers previously unknown recessive condition 

Researchers have discovered how genetic mutations can cause neuro-developmental disorders, including a previously unknown recessive condition.  Scientists at the University of Oxford and the Francis Crick Institute, in collaboration with international partners, have made advances in understanding how mutations in a single non-coding gene contribute to neurodevelopmental… Read More

#News

Knee pain
#Arthritis #Osteoarthritis #University of Oxford

Gum cells show potential as cure for knee arthritis 

The world’s first patient has been treated for knee osteoarthritis (OA) using gum cells from a human donor.  The patient was treated at Oxford University Hospitals, UK using Allogenic Gingival Fibroblast (aGF) Therapy, a treatment developed by biotechnology startup Scarcell Therapeutics.  The therapy is designed to prevent… Read More

#News

Vaccine
#Africa #University of Oxford #Vaccines

Oxford’s Lassa fever vaccine administered in trial 

The first volunteer has been dosed in a first-in-human trial of the Lassa vaccine, marking an unprecedented step towards treating Lassa fever.  The vaccine, developed by the University of Oxford, is being assessed for its safety and the immune response it triggers in volunteers. Thirty-one people aged… Read More

#News

University of Birmingham
#Autoimmune disease #Collaboration #Funding #Immune system #Osaka University #University of Birmingham #University of Oxford

Birmingham Uni and Nobel winner secure inflammation funding

Scientists and clinician-scientists at the University of Birmingham will lead a major research programme to transform the treatment of autoimmune diseases by halting chronic inflammation at its source.  Backed by a £3.83 ($5.1) million Wellcome Discovery Award, Birmingham researchers will join 2025 Nobel Prize winner Professor Shimon… Read More

#News

Degeneration of dopaminergic neuron in Parkinson's disease
#Depression #Drug repurposing #Parkinson's #Psychiatry #Treatment-resistant depression #University of Oxford

Dopamine-boosting Parkinson’s drug treats depression

A drug used for Parkinson’s disease has been shown to be effective in reducing the symptoms of difficult to treat depression, in a study led by the University of Oxford.  In the largest clinical trial to date, pramipexole was found to be substantially more effective than a… Read More

#Editor's Choice #News

#Career #Drug development #Drug discovery #England #From the top #Golden Triangle #Interview #Medicines Discovery Catapult #Nanomedicine / nanotechnology #Northern Ireland #Scotland #UK #University of Oxford

New podcast: UK Spotlight: Innovation and discovery

This is the latest episode of the free DDW narrated podcast, titled “UK Spotlight: Innovation and discovery”, which covers three articles written for DDW Volume 24 – Issue 4, Fall 2023. They are called: “Where is the drug discovery expertise happening in the UK?”, “From the top: Dr… Read More

#News

Mosquito
#Collaboration #Immunology / Virology & Vaccines #Malaria #Recipharm #University of Oxford

Research partners advance two malaria vaccine candidates

The University of Oxford and ReciBioPharm, Recipharm’s Advanced Biologics division, are expanding their long-standing collaboration with the development of two blood-stage malaria vaccine candidates for Phase I/II clinical trials.   Since 2016, the collaboration has delivered five vaccine candidates and will now actively progress the manufacture of R78C… Read More

#News

Close up of vaccine syringe
#Bacteria #Immunology / Virology & Vaccines #University of Oxford #Viral vectors

Gene-based vaccine shows promise in early-stage trial

Trial results have revealed encouraging results for a new vaccine targeting group B meningococcus (MenB) and established that a gene-based vaccine platform can induce protective antibody responses against bacteria.  The investigational vaccine, ChAdOx1 MenB.1, developed by researchers at the University of Oxford, was shown to be safe… Read More

#News #Trending News

Vaccine vial and syringe
#Cancer vaccine #GSK #Immuno-oncology #Oncology #University of Oxford

Oxford and GSK launch £50m cancer vaccines programme

GSK and the University of Oxford will invest up to £50 ($62) million to advance the understanding of how cancer develops, which could inform the future development of vaccines.  The agreement establishes the GSK-Oxford Cancer Immuno-Prevention Programme, which unites expertise from four departments across the University and builds on Oxford’s… Read More

#Business & Investment #Cancer Research #News

Genetics
#Colorectal cancer #Genetics / genomics #The Institute of Cancer Research #The University of Manchester #University of Leeds #University of Oxford

Genetic causes of colorectal cancer revealed in new study

A new study has provided the most comprehensive analysis to date of the genetic makeup of colorectal cancer (CRC), providing unique understanding of its response to treatment. The research was led by UK universities, including the University of Oxford, The Institute of Cancer Research, London, the… Read More

#Cancer Research #News